Report: Michigan Monthly Cannabis Sales Outpace California for First Time

a word from our sponsors:

advertisement

advertise here

The Michigan cannabis industry sold more legal cannabis products in March than any other state, even beating out California, which has until now been the country’s top-selling state, according to BDSA data outlined in an SF Gate report.

The data showed that Michigan retailers sold 22 million cannabis products in March this year, while California cannabis shops sold just 21.3 million products. It was the first time cannabis industry data showed that a state other than California had sold the most cannabis products.

But while Michigan may have sold more cannabis products overall, the California industry still generates more revenue, according to sales data showing that California sold $1 billion worth of cannabis in the first three months of the year, while Michigan retailers sold just $786 million, the report said.

The disparity between products sold and overall revenue is most likely due to significant price differences between the states that results in Michigan offering cheap, legal cannabis products while the California market continues to struggle with high prices. Michigan also benefits from having neighboring states without legal cannabis programs in place, whereas California’s neighbors have already adopted adult-use reforms.

“Michigan is unquestionably better at running the legal cannabis market than California. Michigan illustrates the ways that California has squandered the opportunity.” — Cannabis consultant Hirsh Jain, via SF Gate

The BDSA data tracked purchases including cannabis flower, edibles, or vape pens but did not include the purchasing of paraphernalia including rolling papers or pipes.

End


Ohio Dispensaries Can Apply for Adult-Use Permits Starting Today

a word from our sponsors:

advertisement

advertise here

Starting Friday, Ohio’s 132 licensed medical cannabis dispensaries can apply for permits allowing adult-use sales per last year’s successful legalization voter initiative, 3News reports.

The applications could take up to two weeks to process, which would keep the state on track to meet regulators’ anticipated launch of adult-use sales by the end of the month.

Meanwhile, the state’s existing medical dispensaries are making plans for their expanded operations under the anticipated adult-use sales permits, the report said. AJ Caraballo, the retail director for the Cleveland Heights-based dispensary Amplify, said their company was making a special effort to maintain its regular services for registered cannabis patients.

“We want to make sure that our medical patients will be able to skip the lines and still get priority care here while we’re still excited to welcome our adult-use (marijuana) consumers.” — Caraballo, via 3News

After the initial wave of adult-use licensing, officials plan to continue working on the state’s cannabis regulatory framework so that newcomer cannabis companies can get their shot in the industry, the report said. The full adult-use cannabis industry launch is expected sometime in September.

As of May, several dozen Ohio towns and municipalities had opted for at least temporary bans on adult-use cannabis companies in their jurisdictions.

End


Alabama Medical Cannabis Rollout Still Months Away

a word from our sponsors:

advertisement

advertise here

The rollout of Alabama’s medical cannabis program is still months away – at least – as the state Medical Cannabis Commission (AMCC) remains embroiled in lawsuits, WBRC reports. Licenses were issued nearly a year ago but since then, missteps by the commission and related lawsuits have forced the program to a halt

During an appearance on the Capitol Journal, AMCC Director John McMillan described “most” of the lawsuits as “frivolous” and said that “nobody’s more frustrated” than the commission and its staff. 

“But they have been used as a delaying tactic. I hope, to some extent, a lot of the litigation came from the fact of – ‘let’s just block everything, let’s just keep the commission from being able to do anything. Let’s just shut this program down through the courts and get something settled in the legislature.’” — McMillan via WBRC 

In an interview with WBRC, William Somerville, an attorney for Alabama Always, one of the companies denied a license by the AMCC which is suing the commission, described McMillan’s comments as “just not true” but admitted he could understand where the commissioner was coming from – “knowing that this is just dragging out.” 

“The commission violated the law in numerous ways, and continues to violate the law,” Somerville said. “The only thing that holds the process back is their refusal to comply with the law. If they followed the law, this would all be over with and patients would be getting the medication they need.” 

McMillan said he is hopeful the program could launch “within a matter of months,” however, Somerville described that as “optimistic.”  

“I think there’s still a possibility to get this done within a year,” Somerville said, “but the courts have to get involved with it and force the commission to follow the law.” 

End


Canopy Growth Acquires Acreage Holdings

a word from our sponsors:

advertisement

advertise here

Canadian cannabis firm Canopy Growth on Tuesday agreed to acquire all of the issued and outstanding Class E shares of Acreage Holdings, paving the way for a full takeover of the company. Canopy also recently acquired Wana Wellness, LLC and the CIMA Group, LLC, and 77% of Lemurian, Inc, or Jetty, which CEO David Klein described in a press release as “major steps forward and consistent with the strategy outlined by Canopy Growth.” 

“With the acquisition of Jetty and two of the three Wana business units now complete, Canopy USA is demonstrating its executional capabilities, and we anticipate that these actions will drive growth and the realization of commercial synergies across Canopy USA’s operational platform.” — Klein in a statement 

Closing of the Acreage acquisition remains subject to closing conditions. Canopy will also acquire Acreage’s $99.8 million in outstanding debt in exchange for $69.8 million in cash and the release of approximately $30.1 million that was held in escrow pursuant to the agreement. 

“…We’re excited to see this advancing as more of Canopy USA’s priority markets come online for adult use across the Midwest and Northeast,” Klein said in a statement. 

Another Canopy acquisition — of Mountain High Products, LLC — is expected to close in the first half of fiscal year 2025.   

End


New Jersey Cannabis Company Names Strain After Governor

a word from our sponsors:

advertisement

advertise here

A Bloomfield, New Jersey cannabis company has named a strain after Gov. Phil Murphy (D), WHYY reports. ‘Murphy’s Sourz,’ cultivated by Prolific GrowHouse, is described as a delightful mix of sour lemon, sweet tangerine, with hints of diesel and pine” and was officially launched in January.  

David Nicolas, CEO of Prolific, said the strain was intended to get the governor’s attention and led to Murphy visiting the company this week. During the visit, during which Murphy posed for a picture with a flier promoting the strain, the governor said he was “honored.” 

“I still want to see… more equity, more reward and redemption for the folks who were crushed by the war on drugs.” — Murphy, during the visit, via WHYY 

 

View this post on Instagram

 

A post shared by Governor Phil Murphy (@govmurphy)

Murphy’s visit also intended to highlight a minority-owned New Jersey cannabis business. Nicolas is a first-generation Haitian-American who grew up in Trenton. Nicolas told WHYY that he believes his employee cohort, with an average age of 25, “is probably the youngest in the nation, operating a legal cannabis business.” 

“But everyone here has hustle,” Nicolas said, “and is definitely dedicated towards this company.” 

Nicolas did note that the lack of business capital is “where the diversity is going to not be the same” for cannabis businesses. 

”I think the state can do a little better,” he said, “provide more grants, allow the grants that are open for businesses that are non-cannabis to be open for cannabis businesses.”

End


U.S. House Approves Spending Bill Amendment Allowing VA to Recommend Medical Cannabis

a word from our sponsors:

advertisement

advertise here

The House of Representatives this week approved amendments to a major federal spending bill that would authorize the Department of Veterans Affairs (VA) to accept medical cannabis use by veterans, and expand research efforts into psychedelics, Marijuana Moment reports. The amendments have been attached to the Military Construction, Veterans Affairs, and Related Agencies (MilConVA) Fiscal Year 2024 Appropriations Bill.

Under the medical cannabis amendment brought by Congressional Cannabis Caucus co-chairs Reps. Brian Mast (R-FL), Earl Blumenauer (D-OR), Barbara Lee (D-CA), and Dave Joyce (R-OH), veterans would no longer be barred from participating in state-legal medical cannabis programs. Lawmakers approved the amendment on Tuesday in a 290-116 vote.

“My proposed amendment, I believe, is common sense. It allows doctors in the VA — those that deal with veterans — to give advice to their veteran patients. That seems simple enough, but under the status quo, VA doctors are limited in essential treatment options that they can offer to their patients and treatments that patients that are not veterans can readily assess in many states.” — Mast, in a statement

“It’s unfortunate that the Department of Veterans Affairs is trapped in time, not giving veterans the full benefits of medical cannabis,” said Blumenauer, who has announced he will be retiring later this year at the end of his term.

Similar VA-focused cannabis provisions were approved last year in both the House and Senate but the reforms ultimately failed to reach the final version of the bill, the report said.

Lawmakers also approved on a voice vote two psychedelics-focused amendments: one that calls on the VA to support research investigating psychedelics as a treatment for conditions common among military veterans, and another calling on the VA to send Congress a report detailing the potential implementation of MDMA-assisted therapy if the drug were to become federally approved.

End


South Dakota Legalization Bid Approved for November Ballots

a word from our sponsors:

advertisement

advertise here

South Dakota Secretary of State Monae Johnson announced the validation of a petition to put a cannabis legalization question before voters during the 2024 general election, the Associated Press reports.

It will be the third election in a row that South Dakota voters have considered legalizing adult-use cannabis — the last time voters considered it in 2022, the proposal was defeated with 53% of voters rejecting the reforms. Meanwhile, voters passed sweeping cannabis legalization language in 2020 but that measure was ultimately struck down by the state Supreme Court.

Measure 29, supported by South Dakotans for Better Marijuana Laws (SDBML), seeks to legalize cannabis possession for adults aged 21 and older and allow for limited cannabis home grows. The proposal does not include rules for a regulated cannabis marketplace but legalization supporters plan to work alongside lawmakers to that end if the initiative is successful.

“We firmly believe that South Dakotans deserve to make their own choices on how they live their lives, including the freedom to responsibly use cannabis.” — SDBML’s political director Zebadiah Johnson, via the AP

Ballot proposals in South Dakota require at least 17,508 valid voter signatures to qualify; this year’s legalization proposal was validated with 22,558 signatures.

End


South Africa Broadly Decriminalizes Cannabis

a word from our sponsors:

advertisement

advertise here

Before last week’s elections, South African President Cyril Ramaphosa gave final approval to a bill to decriminalize cannabis, making the nation the first in Africa to legalize cannabis for personal use. President Ramaphosa signed the Cannabis for Private Purposes Act on May 28, which removed cannabis from the nation’s Drugs and Drug Trafficking Act. 

In a press release, Ramaphosa said the move “will further enable amendment of the Schedules to the Medicines and Related Substances Act and provide for targeted regulatory reform of the Plant Breeders Rights Act and the Plant Improvement Act, as well as other pieces of legislation that require amendment to allow for the industrialization of the cannabis sector.” 

“The Bill further guides the medically prescribed administration of cannabis to a child while also protecting children from undue exposure to cannabis. It provides for an alternative manner by which to address the issue of the prohibited use, possession of, or dealing in, cannabis by children, with due regard to the best interest of the child. It also prohibit the dealing in cannabis.” — Ramaphosa in a statement 

Ramaphosa’s party, the African National Congress, lost its majority in Congress during elections on May 29. 

Under the law adults in South Africa may possess unlimited cannabis seeds and seedlings, up to four flowering plants per person or eight per household in a private place, up to 100 grams of flower in a public place; and up to 600 grams of dried cannabis per person or 1,200 grams per household in a private place. Adults may smoke and consume cannabis in private places and gift, without remuneration, up to 30 seeds or seedlings, one flowering plant, or 100 grams of cannabis flower.

End


Canada Has Issued Few Pardons for Cannabis Crimes Since Reforms Passed in 2019

a word from our sponsors:

advertisement

advertise here

Since August 2019, Canada has issued just 845 pardons for cannabis crimes, according to Board of Pardon data outlined by the CBC. The government says it also doesn’t know how many possession records have been “sequestered” under a different program.  

Canada legalized cannabis federally in 2018 and the government estimated that 10,000 citizens would be eligible for conviction relief. The Parole Board of Canada told the CBD that more than 1,300 citizens applied for pardons but that hundreds of applications were either incomplete or ineligible.  

Andrew Tanenbaum, director of the non-profit organization Pardons Canada, told the CBC that the pardon process is tedious and that some Canadians with eligible records may be apathetic about applying.

An alternative was launched in 2022 that should automatically “sequester” records for simple possession, which would prevent records from showing up on background checks. That program gave the government two years to sequester some records for cannabis possession and other drugs, the report says, but NDP MP Randall Garrison – who backed the amendment to sequester records – told the CBC that “it’s clear [the program] doesn’t work.”

“It’s a bureaucratic nightmare. The amount of bureaucracy that is required to do that is probably much more complicated than the pardon system.” — Tanenbaum to the CBC

Jean-Sébastien Comeau, a spokesperson for Public Safety Minister Dominic LeBlanc, indicated that the government intends to meet the program’s November deadline.

“The sequestration of criminal records for simple possession of cannabis is a significant undertaking that requires the cooperation of our provincial, territorial and municipal partners,” Comeau said in an email to the CBC.

“We will continue to work with them, as we have since the coming-into-force of this legislation, to ensure we meet that deadline.”

 

End


Vermont Medical Cannabis Patient Appeals Denial of Unemployment Benefits to State Supreme Court

a word from our sponsors:

advertisement

advertise here

A Vermont man fired from his job for medical cannabis use has appealed the state decision to deny a portion of his state unemployment benefits to the state Supreme Court, the Insurance Journal reports. Ivo Skoric, 59, representing himself, told the justices during a hearing last week that he is legally prescribed medical cannabis by a doctor and his work performance is excellent and not impacted by the medicine.  

However, according to Skoric, in January 2023 he was terminated from his job at Marble Valley Regional Transit District in Rutland for misconduct after failing a drug test. Skoric’s job was to clean and fuel buses and drive them into and out of the garage onto a lot. The misconduct disqualified him from the benefits, according to the state.

“As a medical cannabis patient in Vermont to treat disabling conditions under Vermont’s Fair Employment Practices Act disability provisions, I should be protected by state agencies. I should not be disqualified from receiving unemployment.” — Skoric via the Insurance Journal

Skoric originally appealed to the state Employment Security Board after it was determined he was ineligible for state unemployment benefits for about a month and his maximum benefit was capped. In September 2023, the board agreed with an administrative law judge who ruled that Skoric engaged in conduct prohibited by his employer’s drug and alcohol policy, “exposing him to discipline including termination of his employment.” The judge determined that because he was discharged for misconduct, he was disqualified from those benefits.

Jared Adler, a lawyer representing the Vermont Department of Labor, argued that the court should affirm the board’s decision because “Vermont’s drug code does not guarantee unemployment benefits to people who test positive during a random drug screening” and that Skoric was discharged for misconduct for violating an acknowledged workplace safety policy.

End


FDA Highlights Concerns About Research Investigating MDMA as PTSD Treatment

a word from our sponsors:

advertisement

advertise here

The U.S. Food and Drug Administration (FDA) on Friday posted its initial review of the hallucinogen MDMA, commonly known as molly or ecstasy, which highlights concerns about the substance’s potential health effects when used as a treatment for post-traumatic stress disorder (PTSD), the New York Times reports.

The FDA — which granted MDMA a “breakthrough therapy” designation in 2017, fast-tracking its research process — said initial research results were potentially flawed due to imperfections in the research process. Specifically, the agency suggested it would be too easy for the study’s participants and therapists alike to determine who had been given MDMA versus a placebo, which would create bias, the report said. The agency also noted “significant increases” in blood pressure and the increased potential for “cardiovascular events” as potential points of concern.

MDMA is currently registered as Schedule I under the Controlled Substances Act, which is supposed to be reserved for only the most dangerous and addictive drugs with “no currently accepted medical use and a high potential for abuse.”

If the drug is approved as a treatment for PTSD, it would be the second monumental shift in federal drug policy in recent times after the Biden Administration announced earlier this year cannabis would be moved from Schedule I to Schedule III. It would also be the first new therapy approved for the treatment of PTSD in more than 20 years.

The FDA released its draft rules for the research of psychedelic drugs in June.

Meanwhile, Australia last year legalized medical MDMA and psilocybin — the naturally occurring psychedelic ingredient in hallucinogenic mushrooms — as treatments for PTSD and depression, respectively.

End


Louisiana Lawmakers Pass Hemp Product Regulations, Reject Proposed Ban

a word from our sponsors:

advertisement

advertise here

The hemp products industry in Louisiana has avoided an industry-wide crisis after state lawmakers rejected a proposal that would have shut down about 2,000 hemp companies in the state, the Louisiana Illuminator reports.

But while the Senate proposal to effectively end the hemp industry died in the House, senators on Friday passed — with adjustments — House Bill 952, which seeks to restrict the types of products that are allowed to contain hemp-derived THC and the amount per serving of THC. The bill passed the Senate 37-1 but the House needs to approve the senators’ changes by Monday evening, which is the end of the legislative session, the report said.

Louisiana lawmakers have been considering the competing hemp product regulatory proposals for weeks. At one point on Friday, state representatives considered amendments to the Senate’s industry ban, looking for common ground by banning the use of intoxicating ingredients in hemp products. The amendments were rejected 39-60 and the bill ultimately failed to advance.

“I know there are a lot of you in this room who smoke weed, who ingest weed. If you don’t vote against this, I think you’re being a huge hypocrite.” — Rep. Mandie Landry (D-New Orleans), in a statement

Meanwhile, in the U.S. House of Representatives, lawmakers have attached an amendment to the federal Farm Bill that would effectively ban the sale of hemp-derived intoxicating products. The amendment’s future is uncertain in the divided House and Senate.

End


Florida Gov. Considering Vetoing Bill to Ban Delta-8 THC

a word from our sponsors:

advertisement

advertise here

Despite coming out publicly against the state’s upcoming adult-use cannabis legalization vote, Florida Gov. Ron DeSantis is moving toward vetoing a proposal to ban intoxicating hemp products in the state, CBS News reports.

The bill, passed in March, seeks to prohibit most hemp-derived THC products and would impose strict new regulations on the state’s hemp industry, effectively killing a billion-dollar industry that brings about 100,000 jobs to the state. The governor hopes that by throwing a lifeline to the intoxicating hemp products industry, hemp companies would in turn help finance the effort to block the upcoming cannabis legalization ballot initiative, which poses a similarly existential threat to the hemp industry, the report said.

An anonymous Florida official told CBS News, “It’s been flying under the radar, but he’s going to veto. The marijuana people are furious, and they are scrambling.”

Hemp advocates and industry representatives have also started pressuring the governor to veto the hemp restrictions, Health News Florida reports.

Federal lawmakers, meanwhile, are weighing what would effectively be an outright ban on hemp-derived delta-8 THC products and other intoxicating hemp products. That proposal comes as an amendment to the Farm Bill, introduced last week in the House, that would redefine legal hemp products as either non-intoxicating cannabinoid products or “industrial hemp” products like fiber or food. The amendment would depart from the country’s original hemp legalization language, which legalized essentially all products sourced from hemp, even intoxicants that were synthesized from the plant’s naturally occurring cannabinoids.

End


Minnesota Bill to Allow Early Launch of Cannabis Cultivation Signed Into Law

a word from our sponsors:

advertisement

advertise here

Minnesota will award cannabis cultivation licenses ahead of schedule this year under a proposal signed into law by Gov. Tim Walz (D), the Star Tribune reports.

The proposal seeks to better prepare the state for next year’s launch of its adult-use cannabis market. Any cannabis grown under the early licenses cannot be processed or sold until the general licensing process is completed sometime next year.

Previously, only certain social equity applicants would have been allowed to launch their cultivation businesses before next year.

Other changes to the cannabis program signed into law last Friday include expansions that would qualify between 30% and 40% of Minnesota adults as social equity applicants, and license caps to prevent oversaturation during the market’s first two years of retail dispensaries and other businesses. The bill also establishes a “qualified lottery” by the Office of Cannabis Management for next year’s distribution of cannabis licenses, the report said, but applicants will first need to meet certain qualifications including holding appropriate property and having operational plans in place.

Lastly, the bill will let Minnesota doctors recommend medical cannabis for the treatment of any condition they see fit and will allow registered patients to designate caregivers who can grow up to eight plants on their behalf.

End


Study: Terpenes May Offer Pain Relief for Chemo-Induced Neuropathic Pain

a word from our sponsors:

advertisement

advertise here

A study published this month in the journal Pain suggests that cannabis terpenes – the compounds that give plants their aroma and taste – offer an alternative to chemotherapy-induced neuropathic pain relief without any side effects. The study found that terpenes were as effective as morphine at reducing chronic neuropathic pain and a combination of the two analgesics further enhanced pain relief without negative side effects.  

The study, led by John Streicher, PhD, a member of the Comprehensive Center for Pain & Addiction and a professor of pharmacology at the College of Medicine – Tucson, used a mouse model of chemotherapy-induced neuropathic pain, which occurs when highly toxic chemotherapy medications cause nerve damage that results in pain. 

The terpenes were tested individually and compared with morphine and the team found that each terpene was successful in reducing the sensation of pain at levels near to or above the peak effect of morphine. When the terpenes were combined with morphine, the pain-relieving effects of all five terpene and morphine combinations were significantly increased. 

“We looked at other aspects of the terpenes, such as does this cause reward? Is this going to be addictive? Is it going to make you feel awful? What we found was yes, terpenes do relieve pain, and they also have a pretty good side effect profile.” — Streicher, in a statement, via the University of Arizona 

“This brings up the idea that you could have a combination therapy,” Streicher added, “an opioid with a high level of terpene, that could actually make the pain relief better while blocking the addiction potential of opioids.” 

The paper, “Terpenes from Cannabis sativa induce antinociception in a mouse model of chronic neuropathic pain via activation of adenosine A2A receptors.” is the first to examine the side effects of terpenes in their role as potential pain relievers.  

End


Missouri Has Spent $19M in Cannabis Taxes on Veterans, Substance Use Treatment, Public Defenders

a word from our sponsors:

advertisement

advertise here

Cannabis taxes in Missouri have generated more than $19 million for supporting military veterans, expanding the state’s substance use treatment programs, and the Public Defenders System, the Missouri Independent reports. Last fall, the programs each received $1.3 million and another $5.1 million each earlier this month. 

Amy Moore, director of the Division of Cannabis Regulation, told the Independent that “It is so rewarding to see the impact of this voter-approved program on organizations that provide vital services to Missourians.” 

The funds sent to the Missouri Veterans Commission are used to pay for health care and other services for military veterans and their dependent families; the funds sent to the public defenders system helps pay legal fees for low-income residents; while the drug treatment programs are operated out of the Department of Health and Human Services and help individuals with job placement, housing, and counseling.   

In March, the state set a new cannabis sales record, totaling $125 million.  

In January, Moore indicated that adult-use cannabis sales in the state had led to $58 million in revenues for the state from taxes and annual fees. So far, $8.2 million has been used to pay the state’s operating costs. The state also uses cannabis-derived funds to pay for costs incurred by the court system for expunging former cannabis-related crimes that are now legal under state law. 

End


Minnesota Social Equity Rules Could Cover Between 30%-40% of Adults in the State

a word from our sponsors:

advertisement

advertise here

Under Minnesota’s cannabis industry social equity rules, between 30% and 40% of adults in the state could qualify as social equity applicants, the Minnesota Reformer reports. The rules were approved by state lawmakers earlier this year. 

The state’s social equity rules cover: 

  • individuals who have lived for five years in a neighborhood where more than 20% of residents live in poverty or on food stamps, or where the median income is less than 80% of the statewide or metro area;  
  • those who have lived for five years in a neighborhood with high levels of “social vulnerability” as defined by the Centers for Disease Control (CDC); 
  • military veterans or members of the National Guard; 
  • individuals convicted of a cannabis offense in the past, or had a close family member convicted of an offense; 
  • small farmers with less than $100,000 in annual sales; 
  • and those who have lived for five years in a neighborhood that has seen a “disproportionate” rate of the enforcement of previous cannabis laws, as determined in a forthcoming study by the Office of Cannabis Management. 

Minnesota Reformer estimated the data using federal Census Bureau and CDC data and found that more than a third of the state’s 1,504 census tracts – small subdivisions of cities and counties – likely qualify based on the poverty, income, food stamp, and social vulnerability criteria, as long as they’ve lived in those neighborhoods for at least five years. According to the data, about 1.1 million people, or about a quarter of the state’s 4.4 million adults, have lived within those tracts for at least five years and the state has about 327,000 veterans – of which 100,000 live in those census tracts – which brings the total to about 1.3 million adults, or about 30% of the population. 

Those figures don’t include those individuals with prior cannabis convictions – of which there are tens or even hundreds of thousands when considering family members – or the small farm operators, or those who live in neighborhoods that had been disproportionately targeted by the previous enforcement of cannabis laws.  

End


DEA Says THCA Not Legal Under Federal Law

a word from our sponsors:

advertisement

advertise here

A top official at the Drug Enforcement Administration (DEA) recently wrote in a letter that the federal 0.3% cap on delta-9 THC in hemp-based products also applies to delta-9 THCA, which is a similar cannabinoid, Marijuana Moment reports. THCA is typically created by decarboxylating (or heating up) the more well-known cannabinoid delta-9 THC.

Terrence Boos, chief of DEA’s drug and chemical evaluation section, confirmed in a letter on May 13 — written in response to a query by attorney Shane Pennington about the federal legality of delta-9 THCA — that the agency believes the 0.3% THC cap also applies to THCA.

“In regards to THCA, Congress has directed that, when determining whether a substance constitutes hemp, the delta-9 THC concentration is to be tested ‘using post-decarboxylation or other similarly reliable methods. The ‘decarboxylation’ process converts delta-9-THCA to delta-9-THC. Thus, for the purposes of enforcing the hemp definition, the delta-9 THC level must account for any delta-9 THCA.” — Boos, in the letter, via Marijuana Moment

Hemp industry advocates say the interpretation could be disastrous for hemp producers and manufacturers.

“Most hemp growers, even fiber and grain growers, would be out of compliance,” Jonathan Miller, general counsel for the U.S. Hemp Roundtable, said in the report.

The DEA statement comes as federal lawmakers consider an outright ban on most hemp-derived THC products per an amendment added to the House’s version of the national Farm Bill last week. The amendment would re-word the 2018 Farm Bill, which federally legalized industrial hemp and all of its derivatives, to specify there are only two types of legal hemp products: those that contain non-intoxicating, hemp-derived cannabinoids; and those containing hemp-derived fiber and food products.

End


cannabis industry

New York’s Top Cannabis Regulator Resigns Following Governor’s Criticism

a word from our sponsors:

advertisement

advertise here

New York’s top cannabis regulator Chris Alexander resigned on Friday following recent criticisms of the state’s cannabis agency leveled by Gov. Kathy Hochul (D), The City reports.

The governor had announced earlier this month — during a press conference where he was notably absent — that Alexander would be stepping down at the end of his term in September as executive director role of the Office of Cannabis Management (OCM).

“I have been reluctant to write this email due to the deep connection and commitment I have to this work and to this Team. And while I planned to serve out the remainder of my term, I no longer have confidence in my ability to do my job and lead this team effectively under current circumstances.” – Alexander, in an email, via The City

Alexander said in his emailed resignation that “it has been the honor of a lifetime to lead this group of the most dedicated public servants that I have ever encountered” but that “it would be disingenuous for me to not acknowledge how difficult the last several months have been.”

Hochul appointed Alexander to be the inaugural director of New York‘s cannabis agency in September 2021. However, an audit of the cannabis industry’s botched roll-out ordered by the governor in March found that the agency had been hindered by inexperienced leadership and inefficiencies in the licensing process.

Hochul told The City, “I am grateful for Chris Alexander’s work, first in developing and securing the passage of the Marihuana Regulation and Taxation Act and then in launching the Office of Cannabis Management,” according to the report.

End


California Psychedelics Advocates Considering Legalization Initiative

a word from our sponsors:

advertisement

advertise here

California psychedelics advocates are considering a state ballot measure that would legalize the use of drugs like psilocybin and MDMA, according to a KQED report.

State Sen. Scott Weiner (D) — the author of a recently failed state proposal to legalize psychedelic treatment centers — said that he expects to see the issue appear on the 2026 ballot if state lawmakers don’t take action, first.

“We are not giving up, whether that means introducing a new bill or ballot measure, this issue is not going away. We know these substances are helping people turn their lives around.” — Weiner, via KQED

California Gov. Gavin Newsom (D) last year vetoed a proposal to decriminalize certain psychedelic substances including mescaline, DMT, psilocybin, and psilocin. At the time, the governor requested that lawmakers deliver him a psychedelics bill prioritizing therapeutic applications.

Advocates have not yet decided whether the future ballot proposal would address only the therapeutic use of substances like magic mushrooms or whether it would call for a wider decriminalization of psychedelics, the report said.

Meanwhile, multiple studies have shown that psychedelic substances like MDMA and psilocybin — the primary psychedelic ingredient in magic mushrooms — show promise against treatment-resistant mental health afflictions.

Oregon became the first state to vote to legalize therapeutic psychedelics in 2020 but the program there has shown mixed success.

End


Nicki Minaj Detained For Cannabis in Netherlands, Concert Rescheduled

a word from our sponsors:

advertisement

advertise here

Nicki Minaj was forced to postpone a concert in Manchester following an incident in Amsterdam. Dutch police discovered marijuana in Minaj’s bags as she was preparing to leave the Netherlands, leading to delays, according to NPR.

Promoter Live Nation announced that the performance will be rescheduled and that tickets will still be valid. “Despite Nicki’s best efforts to explore every possible avenue to make tonight’s show happen, the events of today have made it impossible,” Live Nation stated. “We are deeply disappointed by the inconvenience this has caused.”

Minaj tweeted that she was stopped at Amsterdam airport, where police found marijuana in her luggage. Cannabis is not legal in the Netherlands, though it is decriminalized and widely available. Netherlands military police spokesperson Robert Van Kapel confirmed that a 41-year-old American woman was fined and released after being caught with “soft drugs.”

Minaj suggested on Twitter that the incident was intended to make her late for the Manchester concert, accusing authorities of jealousy. The Trinidadian-born rapper is on her “Pink Friday 2” tour, with upcoming stops across Europe. She has openly discussed her cannabis consumption in the past.

End


Hemp THC Products Facing National Ban Under Farm Bill Amendment

a word from our sponsors:

advertisement

advertise here

The U.S. market for delta-8 THC and other hemp-derived cannabinoids is facing the possibility of a federal ban after House lawmakers approved an amendment targeting intoxicating hemp products to the federal Farm Bill, according to The Hill.

The amendment, proposed by Illinois Republican Rep. Mary Miller, establishes two distinct categories of legal hemp:

  • “Hemp grown for cannabinoid extraction” — specifically, ““naturally, occurring, naturally derived and non-intoxicating cannabinoids,” and
  • “Industrial hemp,” which covers material grown for non-cannabinoid-related purposes like fiber and food.

These definitions, however, depart significantly from the 2018 Farm Bill’s language, which legalized essentially all products sourced from hemp including delta-9 THC — the main intoxicating ingredient found in cannabis — and other intoxicating cannabinoids. The change, as written, would spell disastrous consequences for the $28 billion hemp product industry.

While the amendment has been added to the House’s version of the Farm Bill, it is not guaranteed to survive the politically divided body. The amendment would also need to be considered by the Senate.

The Hemp Roundtable said in the report the changes were “hemp industry-killing” and asked lawmakers to reject the Farm Bill until the amendment is removed.

Aaron Smith, co-founder of the National Cannabis Industry Association, called for “sensible federal regulations that apply equally to hemp- and marijuana-derived cannabinoid products.”

Earlier this year, 22 attorneys general asked Congress in a letter to restrict the hemp-derived cannabinoid market, arguing that the 2018 federal Farm Bill “unleashed… a flood of products that are nothing less than a more potent form of cannabis.”

Meanwhile, many states have already adopted policies restricting products that contain hemp-derived delta-8 THC and other intoxicating cannabinoids, including some states that already have their own regulated adult-use cannabis industries.

End


Delaware Lawmakers Advance Proposal for Early Adult-Use Sales

a word from our sponsors:

advertisement

advertise here

Lawmakers in the Delaware House Economic Development, Banking, Insurance, and Commerce Committee last week advanced a proposal that would launch adult-use cannabis sales early in the state by letting medical dispensaries begin serving anyone aged 21 or older, WHYY reports.

Sponsored by state Rep. Ed Osienski (D), House Bill 408 would let the state’s licensed medical dispensaries acquire temporary “conversion licenses” that would allow them to sell to medical and adult-use customers alike while the state’s adult-use market comes online. The conversion license fee would cost $100,000 and proceeds would be assigned to the state’s social equity fund.

Osienski told the committee members the proposal would benefit consumers by opening the market faster. “Part of the real issue is brand new cultivation takes a lot of time,” he said, suggesting that a full crop can take up to 18 months.

“This utilizes the existing growth facilities,” he said.

However, some cannabis advocates are concerned that the proposal would be giving certain businesses an unfair advantage during a critical time of the industry’s rollout, the report said.

“This bill will allow six businesses to basically skip the line and get guaranteed licenses when everyone else will likely be subjected to the lottery process where they may not get a license at all, and they certainly won’t get their application fees back if they’re not selected.” — Zoë Patchell, executive director and co-founder of Delaware Cannabis Advocacy Network, via WHYY

Cannabis is currently legal to possess in Delaware but as lawmakers have yet to begin the licensing process, there are no legally approved sources — and home growing is not allowed.

End


Study: Daily Cannabis Use In U.S. Outpaces Daily Alcohol Use

a word from our sponsors:

advertisement

advertise here

There are more Americans who admit to everyday cannabis use than who admit to everyday alcohol use, according to an analysis of national survey data outlined by the Associated Press.

The research, published last week in the journal Addiction, found that in 2022, about 17.7 million people reported using cannabis daily or near-daily, compared to about 14.7 million daily or near-daily drinkers.

The research was based on data from the National Survey on Drug Use and Health, which is conducted annually by the Substance Abuse and Mental Health Services Administration to provide nationally representative data on Americans’ use of tobacco, alcohol, and other drugs. Researchers said they used data from 1,641,041 participants across 27 surveys from 1979 to 2022.

The report noted that alcohol is still more widely used among Americans but that people who consume cannabis are more likely to be habitual users.

“A good 40% of current cannabis users are using it daily or near daily, a pattern that is more associated with tobacco use than typical alcohol use.” — Jonathan Caulkins, Carnegie Mellon University researcher, via the AP

Cannabis is currently fully legal in 24 states and has been legalized for medical use in 38 states. The federal government still classifies cannabis as one of the most dangerous and restricted substances but President Biden recently announced the Department of Justice will move cannabis from Schedule I to Schedule III under federal law.

In March, a Pew Research poll found that 88% of Americans support legalizing cannabis for either medical or adult use, and 57% supported legalizing both forms of cannabis access.

End